International Clinical Trial: HTRA1-Related Cerebral Small Vessel Disease

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128529) titled 'HTRA1-Related Cerebral Small Vessel Disease' on July 22.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Xuanwu Hospital, Capital Medical University

Condition: Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, CARASIL

Intervention: HTRA1 imaging subgroup:None suspected hCSVD:None Imaging healthy control group:None HTRA1-iPSC subgroup:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: HTRA1 imaging subgroup:20;suspected hCSVD:500;Imaging healthy control group:40;HTRA1-iPSC...